The US Food and Drug Administration appears poised to continue with a plan to ban prescription fluoride supplements at a time ...

Gilead Sciences (GILD) stock gains as Needham upgrades the company to Buy from Hold citing its new HIV prevention injectable, ...

The US FDA has appointed George Francis Tidmarsh, MD, PhD, as director of the Center for Drug Evaluation and Research.

Bristol Myers Squibb appoints Cristian Massacesi as EVP, Chief Medical Officer, & Head of Development starting Aug 2025.

Gilead (NASDAQ:GILD) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA) as ...

The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...